Your browser doesn't support javascript.
loading
New frontiers in the management of dyslipidaemia: Proprotein convertase subtilisin/kexin 9 inhibitors and small interfering ribonucleic acid.
Tse, Tim; Wu, Bosco; Willcock, Simon; Vagholkar, Sanjyot.
Afiliação
  • Tse T; BMed, MD, MMed, FRACGP, General Practitioner, Department of Primary Care, Macquarie University, NSW.
  • Wu B; MBBS, BMedSci (Hons), FRACGP, General Practitioner, Department of Primary Care, Macquarie University, NSW.
  • Willcock S; MBBS, PhD, FRACGP, General Practitioner, Professor, Department of Primary Care, Macquarie University, NSW.
  • Vagholkar S; MBBS (Hons), MPH, PhD, FRACGP, General Practitioner, Professor, Department of Primary Care, Macquarie University, Macquarie Park, NSW.
Aust J Gen Pract ; 52(6): 413-416, 2023 06.
Article em En | MEDLINE | ID: mdl-37291822
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Subtilisina / Dislipidemias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Subtilisina / Dislipidemias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article